This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Mitoxantrone Injection USP (2015-08-27)

Starting date:
August 27, 2015
Posting date:
September 2, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-54906

Affected Products

Mitoxantrone Injection USP

Reason

Product may not support the specification results for known impurity prior to expiry.

Depth of distribution

Hospitals (Including pharmacies)

Affected products

Mitoxantrone Injection USP

DIN, NPN, DIN-HIM
DIN 02244614
Dosage form

Solution

Strength

Mitoxantrone 2 mg/mL

Lot or serial number

B024636AAR
B034636AD
C014636AC

Companies
Recalling Firm
Hospira Healthcare Corporation
2600 Alfred Nobel Blvd, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
2600 Alfred Nobel Blvd, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA

Date modified: